DDDR-03. FDA-approved drug repurposing identifies small molecules with antitumor activity and temozolomide sensitization in glioblastoma
DDDR-03。FDA批准的药物再利用研究发现了具有抗肿瘤活性和对胶质母细胞瘤替莫唑胺增敏作用的小分子。
期刊:
影响因子:
doi:10.1101/2025.01.17.633670
Mueller, Mikala C; Blomberg, Rachel; Tanneberger, Alicia E; Davis-Hall, Duncan; Neeves, Keith B; Magin, Chelsea M; McGinnis, J P; Mallannagari, Sai; Guevara, Maria Camila; Curry, Daniel; Arenkiel, Benjamin; de Leeuw, Charles; Brunelle, Megan; Bui, Tiffany; Davare, Monika
